MDT vs. BMY
Compare and contrast key facts about Medtronic plc (MDT) and Bristol-Myers Squibb Company (BMY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MDT or BMY.
Correlation
The correlation between MDT and BMY is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MDT vs. BMY - Performance Comparison
Key characteristics
MDT:
0.12
BMY:
0.56
MDT:
0.28
BMY:
1.10
MDT:
1.04
BMY:
1.13
MDT:
0.05
BMY:
0.34
MDT:
0.36
BMY:
1.39
MDT:
5.72%
BMY:
11.56%
MDT:
17.41%
BMY:
28.43%
MDT:
-57.63%
BMY:
-70.62%
MDT:
-33.34%
BMY:
-22.54%
Fundamentals
MDT:
$104.34B
BMY:
$116.92B
MDT:
$3.27
BMY:
-$3.58
MDT:
1.49
BMY:
1.92
MDT:
$33.00B
BMY:
$47.44B
MDT:
$20.67B
BMY:
$33.40B
MDT:
$9.19B
BMY:
$5.06B
Returns By Period
In the year-to-date period, MDT achieves a 1.48% return, which is significantly lower than BMY's 18.26% return. Over the past 10 years, MDT has outperformed BMY with an annualized return of 3.52%, while BMY has yielded a comparatively lower 2.85% annualized return.
MDT
1.48%
-5.42%
3.11%
2.05%
-3.72%
3.52%
BMY
18.26%
-1.89%
40.54%
16.05%
1.51%
2.85%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MDT vs. BMY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Medtronic plc (MDT) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MDT vs. BMY - Dividend Comparison
MDT's dividend yield for the trailing twelve months is around 2.56%, less than BMY's 4.16% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDT Medtronic plc | 2.56% | 3.34% | 3.44% | 2.39% | 1.95% | 1.87% | 2.15% | 2.24% | 2.34% | 1.88% | 1.66% | 1.92% |
BMY Bristol-Myers Squibb Company | 4.16% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% | 3.31% |
Drawdowns
MDT vs. BMY - Drawdown Comparison
The maximum MDT drawdown since its inception was -57.63%, smaller than the maximum BMY drawdown of -70.62%. Use the drawdown chart below to compare losses from any high point for MDT and BMY. For additional features, visit the drawdowns tool.
Volatility
MDT vs. BMY - Volatility Comparison
The current volatility for Medtronic plc (MDT) is 3.25%, while Bristol-Myers Squibb Company (BMY) has a volatility of 6.04%. This indicates that MDT experiences smaller price fluctuations and is considered to be less risky than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
MDT vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Medtronic plc and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities